IMAGO BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT November 12, 2020Investors’ Rights Agreement • June 25th, 2021 • Imago BioSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of November 12, 2020, by and among Imago BioSciences, Inc., a Delaware corporation (the “Company”) and the investors listed on the Schedule of Investors attached as Schedule A hereto (each an “Investor” and collectively, the “Investors”).